Safety analysis of two different regimens of uracil–tegafur plus leucovorin as adjuvant chemotherapy for high-risk stage II and III colon cancer in a phase III trial comparing 6 with 18 months of treatment: JFMC33-0502 trial

被引：6

作者：

Takashi Tsuchiya

Sotaro Sadahiro

Kazuaki Sasaki

Ken Kondo

Kenji Katsumata

Genichi Nishimura

Yoshihiro Kakeji

Hideo Baba

Takayuki Morita

Keiji Koda

Seiji Sato

Junji Matsuoka

Yoshiyuki Yamaguchi

Hisashi Usuki

Chikuma Hamada

Susumu Kodaira

Shigetoyo Saji

机构：

[1] Sendai City Medical Center,School of Medicine

[2] Tokai University,undefined

[3] Otaru Ekisaikai Hospital,undefined

[4] National Hospital Organization Nagoya Medical Hospital,undefined

[5] Tokyo Medical University,undefined

[6] Japanese Red Cross Kanazawa Hospital,undefined

[7] Kobe University,undefined

[8] Kumamoto University,undefined

[9] Aomori Prefectural Central Hospital,undefined

[10] Teikyo University Chiba Medical Center,undefined

[11] Fujita Health University,undefined

[12] Okayama University Hospital,undefined

[13] Kawasaki Medical School,undefined

[14] Kagawa University,undefined

[15] Tokyo University of Science,undefined

[16] Nerima General Hospital,undefined

[17] Japanese Foundation for Multidisciplinary Treatment of Cancer,undefined

来源：

Cancer Chemotherapy and Pharmacology | 2014年 / 73卷

关键词：

Colon cancer; Adjuvant chemotherapy; Uracil–tegafur (UFT); Leucovorin; Treatment duration;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：1253 / 1261

页数：8

共 225 条

[1]

O’Connell MJ(1998)Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer J Clin Oncol 16 295-300

[2]

Laurie JA(2003)Semimonthly versus monthly regimen of fluorouracil and leucovorin administered for 24 or 36 weeks as adjuvant therapy in stage II and III colon cancer: results of a randomized trial J Clin Oncol 21 2896-2903

[3]

Kahn M(2005)Phase III study of fluorouracil, leucovorin, and levamisole in high-risk stage II and III colon cancer: final report of Intergroup 0089 J Clin Oncol 23 8671-8678

[4]

Fitzgibbons RJ(2006)Oral uracil and tegafur plus leucovorin compared with intravenous fluorouracil and leucovorin in stage II and III carcinoma of the colon: results from National Surgical Adjuvant Breast and Bowel Project Protocol C-06 J Clin Oncol 24 2059-2064

[5]

Erlichman C(2004)Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer N Engl J Med 350 2343-2351

[6]

Shepherd L(2005)Capecitabine as adjuvant treatment for stage III colon cancer N Engl J Med 352 2696-2704

[7]

Moertel CG(2009)Evidence for cure by adjuvant therapy in colon cancer: observations based on individual patient data from 20,898 patients on 18 randomized trials J Clin Oncol 27 872-877

[8]

Kocha WI(2003)Recurrence patterns after curative resection of colorectal cancer in patients followed for a minimum of ten years Hepatogastroenterology 50 1362-1366

[9]

Pazdur R(2006)Adjuvant chemotherapy with uracil–tegafur for pathological stage III rectal cancer after mesorectal excision with selective lateral pelvic lymphadenectomy: a multicenter randomized controlled trial Jpn J Clin Oncol 36 237-244

[10]

Wieand HS(2002)Efficacy of oral UFT as adjuvant chemotherapy to curative resection of colorectal cancer: multicenter prospective randomized trial Langenbecks Arch Surg 386 575-581

← 1 2 3 4 5 6 7 8 9 10 →